#antibodies

Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.

“There are thousands of survivors like myself who would love to be part of an organized effort to help fellow patients and their families.�...

The digestive system breaks down all the molecules we eat—except the antibodies we ingest in breast milk.

Future clinical trials will explore whether cellular and antibody-based therapies can be beneficial as earlier-stage treatments.

First tried in advanced melanoma, monoclonal antibodies have extended some patients’ survival as much as 10 years.